|
76 |
In Patients With Stable Coronary Heart Disease, Low-Density Lipoprotein-Cholesterol Levels < 70 mg/dL and Glycosylated Hemoglobin A1c < 7% Are Associated With Lower Major Cardiovascular Events |
White HD, Stewart RAH, Dalby AJ, Stebbins A, Cannon CP, Budaj A, Linhart A, Pais P, Diaz R, Steg PG, Krug-Gourley S, Granger CB, Hochman JS, Koenig W, Harrington RA, Held C, Wallentin L, STABILITY Investigators |
Am Heart J |
2020 |
|
77 |
Resource and Infrastructure-Appropriate Management of ST-Segment Elevation Myocardial Infarction in Low- And Middle-Income Countries |
Chandrashekhar Y, Alexander T, Mullasari A, Kumbhani DJ, Alam S, Alexanderson E, Bachani D, Badenhorst JCW, Baliga R, Bax JJ, Bhatt DL, Bossone E, Botelho R, Chakraborthy RN, Chazal RA, Dhaliwal RS, Gamra H, Harikrishnan SP, Jeilan M, Kettles DI, Mehta S, Mohanan PP, Naber CK, Naik N, Ntsekhe M, Otieno HA, Pais P, Piñeiro DJ, Prabhakaran D, Reddy KS, Redha M, Roy A, Sharma M, Shor R, Snyders FA, Tan JWC, Valentine CM, Wilson BH, Yusuf S, Narula J |
Circulation |
2020 |
|
78 |
Effect of Dulaglutide on Cognitive Impairment in Type 2 Diabetes: An Exploratory Analysis of the REWIND Trial |
Cukierman-Yaffe T, Gerstein HC, Colhoun HM, Diaz R, García-Pérez LE, Lakshmanan M, Bethel A, Xavier D, Probstfield J, Riddle MC, Rydén L, Atisso CM, Hall S, Rao-Melacini P, Basile J, Cushman WC, Franek E, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T |
Lancet Neurol |
2020 |
|
79 |
Dulaglutide reduces HbA1c irrespective of antihyperglycemic agents, duration of diabetes, BMI and weight loss: A post hoc analysis from the REWIND Trial |
Kwan A, Gerstein H, Xavier D, Basile J, Maldonado J, Raha S, Konig M |
J Am Coll Cardiol |
2020 |
|
80 |
Assessment of Dulaglutide Safety in Older Patient Populations in REWIND |
Konig M, Gerstein HC, Lakshmanan MC, Xavier D, Allen S, Cushman WC, Leiter LA, Raubenheimer PJ |
Journal of the Endocrine Society |
2020 |
|
81 |
Similar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with and without baseline metformin |
Ferrannini G, Gerstein H, Colhoun HM, Dagenais GR, Diaz R, Dyal L, Lakshmanan M, Mellbin L, Probstfield J, Riddle MC, Shaw JE, *Pais P*, et al.. |
Eur Heart J |
2020 |
|
82 |
Urinary Sodium and Potassium, and Risk of Ischaemic and Haemorrhagic Stroke (INTERSTROKE): a case-control study |
Judge C, O'Donnell MJ, Hankey GJ, Rangarajan S, Chin SL, Rao-Melacini P, Ferguson J, Smyth A, Xavier D, Lisheng L, Zhang H, Lopez-Jaramillo P, Damasceno A, Langhorne P, Rosengren A, Dans AL, Elsayed A, Avezum A, Mondo C, Ryglewicz D, Czlonkowska A, Pogosova N, Weimar C, Diaz R, Yusoff K, Yusufali A, Oguz A, Wang X, Lanas F, Ogah OS, Ogunniyi A, Iversen HK, Malaga G, Rumboldt Z, Oveisgharan S, Hussain FA, Yusuf S |
Am J Hypertens |
2020 |
|
83 |
Polypill with or without Aspirin in Persons without Cardiovascular Disease |
Yusuf S, Joseph P, Dans A, Gao P, Teo K, Xavier D, López-Jaramillo P, Yusoff K, Santoso A, Gamra H, Talukder S, Christou C, Girish P, Yeates K, Xavier F, Dagenais G, Rocha C, McCready T, Tyrwhitt J, Bosch J, Pais P; International Polycap Study 3 Investigators |
N Engl J Med |
2020 |
|
84 |
Situational analysis of practice patterns and challenges in cardiovascular disease management: A qualitative study |
Farah Naaz Fathima, Twinkle Agrawal, Padmini Nidhin, *Denis Xavier* |
Int. J of Non communicable Diseases |
2020 |
|
85 |
Premature permanent discontinuation of apixaban or warfarin in patients with atrial fibrillation |
Anthony P Carnicelli, Sana M Al-Khatib, *Denis Xavier*, Frederik Dalgaard, Peter D Merrill, Daniel M Wojdyla, Basil S Lewis, Michael Hanna, John H Alexander, Renato D Lopes, Lars Wallentin, Christopher B Granger. |
Heart |
2020 |
|
86 |
Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE Trial |
Washam JB, Hohnloser SH, Lopes RD, Wojdyla DM, Vinereanu D, Alexander JH, Gersh BJ, Hanna M, Horowitz J, Hylek EM, Xavier D, Verheugt FWA, Wallentin L, Granger CB; ARISTOTLE Committees and Investigators. |
J Thromb Thrombolysis |
2019 |
|
87 |
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial |
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. |
Lancet |
2019 |
|
88 |
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial |
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators |
Lancet |
2019 |
|
89 |
Association between complications and death within 30 days after noncardiac surgery |
Spence J, LeManach Y, Chan MTV, Wang CY, Sigamani A, Xavier D, Pearse R, Alonso-Coello P, Garutti I, Srinathan SK, Duceppe E, Walsh M, Borges FK, Malaga G, Abraham V, Faruqui A, Berwanger O, Biccard BM, Villar JC, Sessler DI, Kurz A, Chow CK, Polanczyk CA, Szczeklik W, Ackland G, Garg AX, Jacka M, Guyatt GH, Sapsford RJ, Williams C, Cortes OL, Coriat P, Patel A, Tiboni M, Belley-Côté EP, Yang S, Heels-Ansdell D, McGillion M, Schünemann HJ, Parlow S, Patel M, Pettit S, Yusuf S, Devereaux PJ; on behalf of the VISION Investigators |
CMAJ |
2019 |
|
90 |
Cardiovascular risk factor reduction by community health workers in rural India: A cluster randomized trial |
Joshi R, Agrawal T, Fathima F, Usha T, Thomas T, Misquith D, Kalantri S, Chidambaram N, Raj T, Singamani A, Hegde S, Xavier D, Devereaux PJ, Pais P, Gupta R, Yusuf S |
Am Heart J |
2019 |